07
Jul
Mumbai (Maharashtra) [India], July 7: Asston Pharmaceuticals Limited, a pharmaceutical and nutraceutical company headquartered in Navi Mumbai, Maharashtra, has announced the opening of its IPO on July 09, 2025, with a proposed issue size of ₹27.56 Crores. The shares are proposed to be listed on the SME Platform of BSE Limited (BSE SME). The issue is being made through a 100% book-building process in accordance with SEBI regulations. Equity Share Allocation QIB Anchor Portion – Up to 6,35,000 Equity Shares Qualified Institutional Buyers (QIB) – Up to 4,25,000 Equity Shares Non-Institutional Investors (NII) – Up to 3,22,000 Equity Shares Retail Individual Investors (RII) – Up to 7,46,000 Equity Shares Market…